102 related articles for article (PubMed ID: 29905998)
1. Gender differences in melanoma prognostic factors.
Farahi JM; Fazzari M; Braunberger T; Caravaglio JV; Kretowicz A; Wells K; Dellavalle RP; Norris D; Alkousakis T
Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29905998
[TBL] [Abstract][Full Text] [Related]
2. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
3. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
4. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
5. High serum vitamin D level correlates with better prognostic indicators in primary melanoma: A pilot study.
Lim A; Shayan R; Varigos G
Australas J Dermatol; 2018 Aug; 59(3):182-187. PubMed ID: 28332194
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between Epidermal Mitotic Density, Atypical Mitotic Figure Density, Breslow Depth, Ulceration, and Dermal Mitotic Rate in Cutaneous Melanoma: A Retrospective Cohort Study.
Marsch AF; McKee RM; Werbel T; Ruo B; Hinds BR
Int J Surg Pathol; 2021 Sep; 29(6):592-599. PubMed ID: 33624542
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in melanoma survival are not related to mitotic rate of the primary tumor.
Joosse A; van der Ploeg AP; Haydu LE; Nijsten TE; de Vries E; Scolyer RA; Eggermont AM; Coebergh JW; Thompson JF
Ann Surg Oncol; 2015 May; 22(5):1598-603. PubMed ID: 25408275
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for metastasis in cutaneous melanoma.
Cherobin ACFP; Wainstein AJA; Colosimo EA; Goulart EMA; Bittencourt FV
An Bras Dermatol; 2018; 93(1):19-26. PubMed ID: 29641692
[TBL] [Abstract][Full Text] [Related]
9. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma.
Barnhill RL; Katzen J; Spatz A; Fine J; Berwick M
J Cutan Pathol; 2005 Apr; 32(4):268-73. PubMed ID: 15769275
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and associations of high-mitotic-rate melanoma.
Shen S; Wolfe R; McLean CA; Haskett M; Kelly JW
JAMA Dermatol; 2014 Oct; 150(10):1048-55. PubMed ID: 25142970
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
Strazzulla LC; Li X; Zhu K; Okhovat JP; Lee SJ; Kim CC
J Am Acad Dermatol; 2019 May; 80(5):1292-1298. PubMed ID: 30654075
[TBL] [Abstract][Full Text] [Related]
13. The importance of ulceration of cutaneous melanoma of the head and neck: a comparison of ear (pinna) and nonear sites.
Augenstein AC; Capello ZJ; Little JA; McMasters KM; Bumpous JM
Laryngoscope; 2012 Nov; 122(11):2468-72. PubMed ID: 23108883
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in thin cutaneous malignant melanoma].
Massi D; Franchi A; Santucci M
Pathologica; 2002 Dec; 94(6):282-9. PubMed ID: 12540991
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node status in melanoma: prognostic value in a tertiary hospital and correlation with mitotic activity.
Mahiques Santos L; Oliver Martinez V; Alegre de Miquel V
Actas Dermosifiliogr; 2014; 105(1):60-8. PubMed ID: 24021663
[TBL] [Abstract][Full Text] [Related]
16. Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma.
Tas F; Erturk K
Int J Dermatol; 2017 Feb; 56(2):166-170. PubMed ID: 27778319
[TBL] [Abstract][Full Text] [Related]
17. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
19. Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions.
Rees MJ; Liao H; Spillane J; Speakman D; McCormack C; Donahoe S; Pohl M; Webb A; Gyorki D; Henderson MA
Eur J Surg Oncol; 2016 Sep; 42(9):1359-66. PubMed ID: 26899940
[TBL] [Abstract][Full Text] [Related]
20. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]